Biotech Values

[mcbio]

BLRX/BL-8020

I've asked and just got an answer: it is indeed an oral NS3/4A protease inhibitor.

Wow, thanks for confirming genisi. I don't know if I want to go as far as saying this renders the BLRX PR misleading (due to claims about a novel target), but it's the kind of PR normally issued by less credible small-cap biotech firms IMHO. I've been pretty bullish on the stock for awhile, given the diverse pipeline and small market cap (though unfortunately never took a position), and even after the pop the market cap seems pretty cheap to me in the grand scheme of things, but this kind of PR now has me second-guessing management credibility. Maybe that's too harsh but that's kind of my gut feel.